Skip to main content

AbbVie Inc. balance sheet

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B

At the end of fiscal 2025 (the year to 31 Dec 2025), AbbVie Inc. reported total assets of $134.0B, $5.23B in cash and equivalents, $68.38B of total debt; shareholders' equity was −$3.27B.

From AbbVie Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

AbbVie Inc. balance sheet, annual
USDFY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$27.00M$5.90B$9.60B$8.35B$8.40B$5.10B$9.30B$7.29B$39.92B$8.45B$9.75B$9.20B$12.81B$5.52B$5.23B
Short-term investments—$2.08B$300.0M$26.00M$8.00M$1.32B$486.0M$772.0M$0.00$30.00M$84.00M$28.00M$2.00M$31.00M$28.00M
Cash and short-term investments$27.00M$7.98B$9.89B$8.37B$8.41B$6.42B$9.79B$8.06B$39.92B$8.48B$9.83B$9.23B$12.82B$5.55B$5.26B
Accounts receivable————$4.73B$4.76B$5.09B$5.38B$5.43B$8.82B$9.98B$11.25B$11.15B$10.92B$12.59B
Inventory—$1.09B$1.15B$1.12B$1.72B$1.44B$1.60B$1.60B$1.81B$3.31B$3.13B$3.58B$4.10B$4.18B$4.95B
Current assets—$15.35B$17.85B$16.08B$16.31B$16.19B$21.22B$16.95B$49.52B$24.17B$27.93B$28.46B$33.00B$25.58B$29.06B
Property, plant and equipment—$2.25B$2.30B$2.48B$2.56B$2.60B$2.80B$2.88B$2.96B$5.25B$5.11B$4.93B$4.99B$5.13B$5.63B
Goodwill$6.10B$6.13B$6.28B$5.86B$13.17B$15.42B$15.79B$15.66B$15.60B$33.12B$32.38B$32.16B$32.29B$34.96B$35.64B
Acquired intangibles—$2.32B$1.89B$1.51B$19.71B$28.90B$27.56B$21.23B$18.65B$82.88B$75.95B$67.44B$55.61B$60.07B$52.64B
Long-term investments—$119.0M$118.0M$92.00M$145.0M$1.78B$2.09B$1.42B$93.00M$293.0M$277.0M$241.0M$304.0M$279.0M$268.0M
Total assets—$27.01B$29.20B$27.51B$53.05B$66.10B$70.79B$59.35B$89.11B$150.6B$146.5B$138.8B$134.7B$135.2B$134.0B
Accounts payable—$556.0M$933.0M$1.40B$1.60B$1.41B$1.47B$1.55B$1.45B$2.28B$2.88B$2.93B$3.69B$2.94B$3.59B
Short-term borrowings—$1.02B$413.0M$425.0M$406.0M$377.0M$400.0M$3.70B$0.00$34.00M$14.00M$1.00M$0.00$0.00$2.50B
Long-term debt · current portion—$22.00M$18.00M$4.01B$2.02B$25.00M$6.01B$1.61B$3.75B$8.47B$12.48B$4.13B$7.19B$6.80B$6.06B
Current liabilities—$6.78B$6.88B$11.39B$10.89B$9.78B$16.64B$17.24B$15.59B$28.66B$35.19B$29.54B$37.84B$38.75B$43.29B
Long-term debt · non-current—$14.63B$14.29B$10.54B$29.24B$36.44B$30.95B$35.00B$62.98B$77.55B$64.19B$59.13B$52.19B$60.34B$58.94B
Operating lease liability————————$360.0M$1.01B$891.0M$920.0M$901.0M$875.0M$883.0M
Finance lease liability————————$27.00M$29.00M$34.00M$34.00M$42.00M$40.00M$41.00M
Total liabilities—$27.36B$24.71B$25.77B$49.10B$61.46B$65.69B$67.80B$97.29B$137.5B$131.1B$121.5B$124.3B$131.8B$137.2B
Retained earnings——$1.57B$535.0M$2.25B$4.38B$5.46B$3.37B$4.72B$1.05B$3.13B$4.78B−$1.00B−$7.90B−$15.49B
Minority interest————————$0.00$21.00M$28.00M$33.00M$37.00M$39.00M$42.00M
Shareholders' equity—−$350.0M$4.49B$1.74B$3.94B$4.64B$5.10B−$8.45B−$8.17B$13.08B$15.41B$17.25B$10.36B$3.33B−$3.27B
Total liabilities and equity—$27.01B$29.20B$27.51B$53.05B$66.10B$70.79B$59.35B$89.11B$150.6B$146.5B$138.8B$134.7B$135.2B$134.0B
Total debt—$15.67B$14.72B$14.98B$31.67B$36.84B$37.37B$40.31B$67.09B$87.06B$77.58B$64.19B$60.29B$68.02B$68.38B
Net debt—$7.70B$4.83B$6.60B$23.26B$30.42B$27.58B$32.25B$27.16B$78.58B$67.75B$54.96B$47.47B$62.46B$63.12B
Net working capital—$2.68B$1.37B−$3.66B−$2.98B$1.31B−$4.72B−$7.58B−$5.99B−$12.94B−$17.01B−$10.28B−$17.65B−$18.69B−$19.46B
Shares outstanding · period end——1.6B1.6B1.6B1.6B1.6B1.5B1.5B1.8B1.8B1.8B1.8B1.8B1.8B

Quarterly

AbbVie Inc. balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$12.81B$18.07B$13.13B$7.26B$5.52B$5.17B$6.47B$5.63B$5.23B$9.39B$6.57B$10.77B
Short-term investments$2.00M$2.00M$27.00M$28.00M$31.00M$1.00M$0.00$42.00M$28.00M———
Cash and short-term investments$12.82B$18.07B$13.16B$7.29B$5.55B$5.18B$6.47B$5.67B$5.26B$9.39B$6.57B$10.77B
Accounts receivable$11.15B$11.95B$11.72B$11.47B$10.92B$12.48B$12.64B$12.77B$12.59B$12.48B$13.82B$13.51B
Inventory$4.10B$4.25B$4.22B$4.45B$4.18B$4.53B$4.96B$4.94B$4.95B$5.05B$5.13B$5.30B
Current assets$33.00B$38.87B$33.82B$27.79B$25.58B$27.68B$29.26B$28.54B$29.06B$33.53B$33.67B$37.48B
Property, plant and equipment$4.99B$4.98B$5.02B$5.14B$5.13B$5.24B$5.28B$5.48B$5.63B$5.69B$5.80B$5.94B
Goodwill$32.29B$33.43B$33.39B$35.30B$34.96B$35.28B$35.64B$35.63B$35.64B$35.57B$35.52B$37.80B
Acquired intangibles$55.61B$62.23B$60.24B$66.65B$60.07B$58.49B$57.03B$54.31B$52.64B$50.87B$49.14B$56.65B
Long-term investments$304.0M$305.0M$272.0M$267.0M$279.0M$287.0M$310.0M$291.0M$268.0M$268.0M$266.0M$387.0M
Total assets$134.7B$148.9B$141.9B$143.4B$135.2B$136.2B$137.2B$133.9B$134.0B$136.5B$135.1B$147.7B
Accounts payable$3.69B———$2.94B———$3.59B———
Short-term borrowings$0.00$3.00M——$0.00$1.59B$5.56B$3.79B$2.50B$0.00$0.00$0.00
Long-term debt · current portion$7.19B$10.19B$12.59B$12.57B$6.80B$3.77B$1.97B$1.98B$6.06B$8.33B$8.34B$8.67B
Current liabilities$37.84B$41.52B$41.91B$43.06B$38.75B$36.40B$39.77B$39.39B$43.29B$42.10B$41.64B$43.10B
Long-term debt · non-current$52.19B$63.80B$58.05B$58.51B$60.34B$64.53B$62.96B$62.97B$58.94B$64.53B$62.48B$72.23B
Operating lease liability$901.0M———$875.0M———$883.0M———
Finance lease liability$42.00M———$40.00M———$41.00M———
Total liabilities$124.3B$140.8B$135.1B$137.4B$131.8B$134.7B$137.3B$136.5B$137.2B$143.1B$141.0B$152.2B
Retained earnings−$1.00B−$2.38B−$3.77B−$4.96B−$7.90B−$9.53B−$11.50B−$14.23B−$15.49B−$17.87B−$17.33B−$16.19B
Minority interest$37.00M$40.00M$43.00M$39.00M$39.00M$42.00M$45.00M$43.00M$42.00M$44.00M$47.00M$45.00M
Shareholders' equity$10.36B$8.01B$6.78B$6.03B$3.33B$1.42B−$183.0M−$2.64B−$3.27B−$6.66B−$5.93B−$4.58B
Total liabilities and equity$134.7B$148.9B$141.9B$143.4B$135.2B$136.2B$137.2B$133.9B$134.0B$136.5B$135.1B$147.7B
Total debt$60.29B$74.00B$70.63B$71.08B$68.02B$69.89B$70.48B$68.74B$68.38B$72.86B$70.82B$80.90B
Net debt$47.47B$55.93B$57.48B$63.79B$62.46B$64.71B$64.01B$63.07B$63.12B$63.47B$64.25B$70.13B
Net working capital−$17.65B−$20.72B−$21.23B−$22.53B−$18.69B−$13.90B−$16.97B−$16.48B−$19.46B−$17.96B−$14.54B−$16.40B
Shares outstanding · period end1.8B1.8B1.8B1.8B1.8B1.8B1.8B1.8B1.8B1.8B1.8B1.8B

The main figures as JSON and plain text. See data and methodology.

ABBV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.